<svg width="1280" height="720" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" overflow="hidden"><defs><clipPath id="clip0"><rect x="0" y="0" width="1280" height="720"/></clipPath></defs><g clip-path="url(#clip0)"><rect x="0" y="0" width="1280" height="720" fill="#FFFFFF"/><path d="M16.8945 16.5466 16.8945 703.453 1263.11 703.453 1263.11 16.5466ZM0 0 1280 0 1280 720 0 720Z" fill="#E8E2E3" fill-rule="evenodd"/><rect x="0" y="0" width="1280" height="720" fill="#FFFFFF"/><path d="M108 108 532 108 532 616 319.243 544.235 108 616 108 108Z" fill="#E8E2E3" fill-rule="evenodd"/><text fill="#332441" font-family="Bembo,Bembo_MSFontService,sans-serif" font-weight="400" font-size="43" transform="translate(206.833 242)">Metabolomic <tspan font-size="43" x="-3.91335" y="57">study of statin </tspan><tspan font-size="43" x="-32.0933" y="113">associated muscle </tspan><tspan font-size="43" x="28.5" y="169">symptoms</tspan></text><rect x="0" y="0" width="12.1196" height="12.1196" stroke="#332441" stroke-width="1.66667" stroke-miterlimit="8" fill="none" transform="matrix(-0.720314 0.693648 0.693648 0.720314 320.162 475.198)"/><path d="M329 484 365.969 484" stroke="#332441" stroke-width="1.66667" stroke-miterlimit="8" fill="none" fill-rule="evenodd"/><path d="M274 484 310.969 484" stroke="#332441" stroke-width="1.66667" stroke-miterlimit="8" fill="none" fill-rule="evenodd"/><path d="M625.5 109.5 1172.5 109.5" stroke="#51ACCB" stroke-width="1.33333" stroke-miterlimit="8" fill="#51ACCB" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-style="italic" font-weight="700" font-size="21" transform="translate(631.354 133)">Background:<tspan font-style="normal" font-weight="400" font-size="21" x="108.907" y="0">The most common reasons for statin intolerance </tspan></text><path d="M631.354 134.843 737.354 134.843 737.354 135.843 631.354 135.843Z" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-weight="400" font-size="21" transform="translate(631.354 154)">are usually related to muscle pain, also known as statin<tspan font-size="21" x="454.207" y="0">-</tspan><tspan font-size="21" x="0" y="22">associated muscle symptoms (SAMS). It remains particularly </tspan><tspan font-size="21" x="0" y="44">difficult to diagnose SAMS since it heavily relied on patients </tspan><tspan font-size="21" x="0" y="65">self</tspan><tspan font-size="21" x="26.6934" y="65">-</tspan><tspan font-size="21" x="35.14" y="65">reporting their symptoms. </tspan></text><path d="M625.5 235.5 1172.5 235.5" stroke="#83A0DA" stroke-width="1.33333" stroke-miterlimit="8" fill="#83A0DA" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-style="italic" font-weight="700" font-size="21" transform="translate(631.354 258)">Objective:<tspan font-style="normal" font-weight="400" font-size="21" x="87.4067" y="0">We want to use metabolite attributes in the Matrix </tspan></text><path d="M631.354 260.483 715.354 260.483 715.354 261.483 631.354 261.483Z" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-weight="400" font-size="21" transform="translate(631.354 279)">Linear Models to shed light on how the metabolome differs in <tspan font-size="21" x="0" y="22">patients with and without statin</tspan>-<tspan font-size="21" x="276.18" y="22">associated muscle symptoms </tspan><tspan font-size="21" x="0" y="44">(SAMS) while adjusting for fish oil supplementation.</tspan></text><path d="M625.5 361.5 1172.5 361.5" stroke="#7067D2" stroke-width="1.33333" stroke-miterlimit="8" fill="#7067D2" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-style="italic" font-weight="700" font-size="21" transform="translate(631.354 384)">Why?:<tspan font-style="normal" font-weight="400" font-size="21" x="61.8467" y="0">The ability to identify patients at risk of SAMS would </tspan></text><path d="M631.354 386.122 690.354 386.122 690.354 387.122 631.354 387.122Z" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-weight="400" font-size="21" transform="translate(631.354 405)">adjust the approach to treatment using lower intensity statins or <tspan font-size="21" x="0" y="22">by lowering the doses of statins and combining them with </tspan><tspan font-size="21" x="0" y="44">non</tspan><tspan font-size="21" x="33.34" y="44">-</tspan><tspan font-size="21" x="41.7867" y="44">statin LDL lowering therapy.</tspan></text><path d="M625.5 486.5 1172.5 486.5" stroke="#AE83DA" stroke-width="1.33333" stroke-miterlimit="8" fill="#AE83DA" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-style="italic" font-weight="700" font-size="21" transform="translate(631.354 510)">Hypothesis:<tspan font-style="normal" font-weight="400" font-size="21" x="105.747" y="0">SAMS lipidome may show variation in </tspan></text><path d="M631.354 511.761 731.354 511.761 731.354 512.761 631.354 512.761Z" fill-rule="evenodd"/><text font-family="Bembo,Bembo_MSFontService,sans-serif" font-weight="400" font-size="21" transform="translate(631.354 531)">triglyceride composition.</text></g></svg>